Coexisting Mitral Regurgitation Impairs Survival After Transcatheter Aortic Valve Implantation

Hisato Takagi1, Takuya Umemoto1,

  • 1Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.

Abstract

Insights

Untreated mitral regurgitation (MR) significantly increases mortality risk after transcatheter aortic valve implantation (TAVI) for aortic stenosis (AS). This meta-analysis confirms apparent MR is linked to higher early and overall death rates post-TAVI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Coexisting mitral regurgitation (MR) impact on survival post-transcatheter aortic valve implantation (TAVI) for aortic stenosis (AS) is unclear.
  • Existing evidence on MR and TAVI outcomes is limited.
  • A comprehensive analysis of adjusted observational studies is needed.

Purpose of the Study:

  • To conduct the first meta-analysis on the association between untreated MR and mortality after TAVI for AS.
  • To summarize contemporary evidence from adjusted observational studies.
  • To evaluate the impact of different grades of MR on post-TAVI survival.

Main Methods:

  • Systematic search of MEDLINE and EMBASE databases up to February 2015.
  • Inclusion of observational studies reporting adjusted hazard ratios (HRs) or odds ratios (ORs) for mortality.
  • Analysis of early (30-day/in-hospital) and overall all-cause mortality in patients with apparent versus unapparent MR.

Main Results:

  • Sixteen studies with 13,672 patients were included.
  • Apparent MR was associated with a significant increase in early mortality (OR 2.17; 95% CI 1.50-3.14).
  • Apparent MR also significantly increased overall all-cause mortality (HR 1.81; 95% CI 1.37-2.40).

Conclusions:

  • Coexisting and untreated apparent MR (moderate to severe) is linked to increased early and overall mortality after TAVI for AS.
  • Findings highlight the importance of addressing MR in AS patients undergoing TAVI.
  • Further research may be warranted to explore management strategies for MR in this population.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
586
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.1K
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.3K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
919
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
818